Given the importance of LTB4 and its involvement in numerous chronic inflammatory as well as metabolic disorders, LTA4H is an attractive therapeutic target that has been pursued by numerous pharmaceutical companies in the past26. The gene discussed is LTA4H; the disease is metabolic disease.